Do you have a model answer for this assigmentTicagrelor (Brilinta®) is an oral, reversible, direct acting platelet inhibitor that has been recently

Do you have a model answer for this assigment Ticagrelor (Brilinta®) is an oral, reversible, direct acting platelet inhibitor that has been recently registered in South Africa for use in acute coronary syndrome (ACS). The current standard treatment in preventing cardiovascular events in patients with ACS is clopidogrel. You are the health economist on your […]